Respiratory syncytial virus: A continuing culprit and conundrum.

Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med (2008) 1.53

Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med (2006) 1.41

Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect (2004) 1.27

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol (2009) 1.23

Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J Virol (2003) 1.23

IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med (2007) 1.22

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. J Virol (2004) 1.18

Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol (2002) 1.17

The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol (2009) 1.15

Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol (2008) 1.14

Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population. Epidemiol Infect (2008) 0.99

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am J Pathol (2001) 0.99

RFI-641, a potent respiratory syncytial virus inhibitor. Antimicrob Agents Chemother (2002) 0.97

Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol (2003) 0.90

Cord blood cytokines and acute lower respiratory illnesses in the first year of life. Pediatrics (2006) 0.90

Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 0.85

Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J Virol (2005) 0.85

Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection. J Virol (2011) 0.80

A hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis. Arch Dis Child (2002) 0.78

Value of Chest Radiographic Pattern in RSV Disease of the Newborn: A Multicenter Retrospective Cohort Study. Crit Care Res Pract (2012) 0.77

Characterization of hospital and community-acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010. Influenza Other Respir Viruses (2015) 0.76

Frequency of pleural effusion in acute bronchiolitis and its effect on prognosis. Multidiscip Respir Med (2011) 0.75